90 data-"https:" "https:" "https:" "https:" "https:" "https:" "Dr" "UCL" "UCL" "UCL" Postdoctoral research jobs at Stanford University
Sort by
Refine Your Search
-
Posted on Tue, 07/29/2025 - 11:14 Important Info Faculty Sponsor First name: Gretchen Faculty Sponsor Last Name: Daily Other Mentor(s) if Applicable: Dr. Anne Guerry, Dr. Lisa Mandle Stanford
-
: $80,000 - $82,000 The Adolescent Ethnic-Racial Identity Development (AERID) Lab, under the supervision of Dr. Adriana Umaña-Taylor at the Stanford Graduate School of Education, is seeking a Postdoctoral
-
Intelligence (HAI), Stanford Digital Economy Lab Postdoc Appointment Term: 1-2 Years Appointment Start Date: Sept 1, 2026 Group or Departmental Website: https://digitaleconomy.stanford.edu/ (link is external
-
Appointment Term: July/August 1, 2026 to June/July 31, 2027 (renewable) Appointment Start Date: August 1, 2026, with some flexibility Group or Departmental Website: https://scale.stanford.edu/ (link is external
-
Scholar Duration: 2 years Start Date: Flexible (anticipated Fall/Winter 2025) Principal Investigator: Dr. Titilola Falasinnu Position Summary The Division of Immunology and Rheumatology at Stanford
-
the scope and impact of our studies. Current research themes include: The impact of GLP-1 receptor agonists on metabolic outcomes and surgical decision-making in bariatric patients Computer vision analysis
-
external) is reimagining the experimental neuroscience pipeline with big data and AI at its core. A central goal of the project is to build a foundation model of the visual brain—a “digital twin” that
-
alongside a team with expertise in flood modeling and collaborators in IIT Bombay. We encourage recent graduates with a PhD or equivalent degree from an epidemiology, biostatistics, data science, computer
-
: Pathology Biomedical Data Science Postdoc Appointment Term: 1 year (renewable) Appointment Start Date: As soon as feasible; February 2026 How to Submit Application Materials: Please email the required
-
data from patients treated with cellular immunotherapies in clinical trials. Utilizing this knowledge, we validate novel manipulatable biomarkers to optimize CAR T-cell activity for patients. Once